Market research
300534.SHE Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 4B
- P/E ratio
- 124.91
- Analyst target
- Not available
- Dividend yield
- 0.1%
- Beta
- 0.22
Community
Investor discussion
1 comment
Sign in to join the 300534.SHE discussion.
5 years, 5 months ago
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd is currently in a long term uptrend where the price is trading 10.4% above its 200 day moving average.
From a valuation standpoint, the stock is 32.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.5.
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd's total revenue rose by 41.2% to $72M since the same quarter in the previous year.
Its net income has increased by 14.6% to $-2M since the same quarter in the previous year.
Finally, its free cash flow grew by 260.6% to $13M since the same quarter in the previous year.
Based on the above factors, Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd gets an overall score of 5/5.